Monthly Archives: November 2022

The Chief Executives of Nuffield Trust and The King’s Fund have co-authored a blog about the community pharmacy vision and strategy project commissioned by PSNC. In the blog the project leads describe the opportunity to broaden the role of community pharmacy and to maximise its potential as a key part of primary care. They reference [...]

The post Vision Project: A blog from Nuffield Trust and The King’s Fund appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Chlordiazepoxide 5mg and 10mg capsules. MSN/2022/092 Tier 3 – High impact Date of issue 2nd November 2022 All suppliers of Chlordiazepoxide 10mg and 5mg capsules are currently out of stock until w/c 7th November 2022 Viatris expect to have sufficient stock [...]

The post Medicine Supply Notification: Chlordiazepoxide 5mg and 10mg capsules appeared first on PSNC Website.

PSNC Chief Executive Janet Morrison OBE this week took part a briefing session of the All-Party Parliamentary Group on Pharmacy, in Westminster Hall. Alongside representatives from AIM, CCA, NPA and RPS, Janet briefed a group of 18 Parliamentarians on the support the sector needs to unlock the full potential of community pharmacy. She conveyed to [...]

The post PSNC CEO briefs MPs on sector challenges and opportunities appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has granted the following final list of price concessions for October 2022 on 02/11/2022: Drug Pack size Price concession Aripiprazole 1mg/ml oral solution 150 £104.90 Bumetanide 1mg/5ml oral solution sugar free 150 £235.00 Chlorphenamine 2mg/5ml oral solution 150 £4.09 Chlorphenamine 2mg/5ml oral solution sugar free 150 £2.80 [...]

The post October 2022 Price Concessions Final Update appeared first on PSNC Website.